Britta Flach, n/a

Fred Hutchinson Cancer Research Center
Seattle, Washington, United States

Disclosure information not submitted.

Presentation(s):

• 225 - The Immunology and Safety of Maternal RSV Vaccination, Infant Nirsevimab Immunization, or Both Products- Interim Analysis of a Randomized Clinical Trial

  Monday, October 20, 2025
  3:27 PM - 3:39 PM US ET